Literature DB >> 10048906

Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study.

P Stratton1, R E Tuomala, R Abboud, E Rodriguez, K Rich, J Pitt, C Diaz, H Hammill, H Minkoff.   

Abstract

OBJECTIVE: To determine obstetric and neonatal outcomes in a cohort of HIV-infected pregnant women and to assess whether HIV-related immunosuppression increases the risk of adverse outcomes of pregnancy.
METHODS: Between 1989 and 1994, interview, physical examination, laboratory, and medical record data were prospectively collected from HIV-infected pregnant women and on their newborns. Factors associated with adverse pregnancy outcome and HIV disease status were correlated with pregnancy outcome using logistic regression analysis.
RESULTS: 634 women delivered after 24 weeks of gestation. Preterm birth, low birth weight, and small-for-gestational-age neonates occurred in 20.5%, 18.9%, and 24.0% of pregnancies, respectively. Factors associated with low birth weight were CD4 percentage <14%, history of adverse pregnancy outcome, pediatric HIV infection, bleeding during pregnancy, and Trichomonas infection. Preterm birth was associated with CD4 percentage <14%, a history of adverse pregnancy outcome, and bleeding during pregnancy. Being small for gestational age was associated with maternal hard drug use during pregnancy, Trichomonas infection, history of adverse pregnancy outcome, and hypertension.
CONCLUSIONS: Adverse pregnancy outcomes are common for HIV-infected women and are associated with low maternal CD4 percentage and pediatric HIV infection. Preterm birth, low birth weight, and small-for-gestational-age ranking, however, are also associated with previously recognized sociodemographic and obstetric factors that are not unique to HIV infection.

Entities:  

Mesh:

Year:  1999        PMID: 10048906     DOI: 10.1097/00042560-199902010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  18 in total

Review 1.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Authors:  Kunjal Patel; David E Shapiro; Susan B Brogly; Elizabeth G Livingston; Alice M Stek; Arlene D Bardeguez; Ruth E Tuomala
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.

Authors:  Jan Walter; Mwiya Mwiya; Nancy Scott; Prisca Kasonde; Moses Sinkala; Chipepo Kankasa; Shuaib Kauchali; Grace M Aldrovandi; Donald M Thea; Louise Kuhn
Journal:  J Infect Dis       Date:  2006-10-19       Impact factor: 5.226

4.  Combination antiretroviral use and preterm birth.

Authors:  D Heather Watts; Paige L Williams; Deborah Kacanek; Raymond Griner; Kenneth Rich; Rohan Hazra; Lynne M Mofenson; Hermann A Mendez
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

5.  High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.

Authors:  Kathleen M Powis; Thomas F McElrath; Michael D Hughes; Anthony Ogwu; Sajini Souda; Saul A Datwyler; Erik von Widenfelt; Sikhulile Moyo; Marisa Nádas; Joseph Makhema; Esther Machakaire; Shahin Lockman; Max Essex; Roger L Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

6.  Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV.

Authors:  V Mave; D Kadam; A Kinikar; N Gupte; D Bhattacharya; R Bharadwaj; K McIntire; V Kulkarni; U Balasubramanian; N Suryavanshi; C Thio; P Deshpande; J Sastry; R Bollinger; A Gupta; R Bhosale
Journal:  HIV Med       Date:  2014-01-14       Impact factor: 3.180

7.  A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia.

Authors:  Marie C D Stoner; Bellington Vwalika; Marcela C Smid; Shalin George; Benjamin H Chi; Elizabeth M Stringer; Jeffrey S A Stringer
Journal:  Int J Gynaecol Obstet       Date:  2016-05-25       Impact factor: 3.561

Review 8.  Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Diagnosis of hypertensive disorders of pregnancy in sub-Saharan Africa: a poorly assessed but increasingly important issue.

Authors:  Joël Fokom-Domgue; Jean Jacques N Noubiap
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-28       Impact factor: 3.738

10.  HIV infection as a risk factor for vaginal dysbiosis, bacterial vaginosis, and candidosis in pregnancy: A matched case-control study.

Authors:  Philipp Foessleitner; Ljubomir Petricevic; Isabell Boerger; Irene Steiner; Herbert Kiss; Armin Rieger; Veronique Touzeau-Roemer; Alex Farr
Journal:  Birth       Date:  2021-01-18       Impact factor: 3.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.